Michele Hauser
Child & Adolescent Psychiatry · Austin, TXNPI 1912026592
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,091 of the $2,646 with a category attached, or 79.0%. 20 manufacturers reported payments, led by Neos Therapeutics, LP at 25.6% of the total.
Across 98 payments — averaging $27.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neos Therapeutics, LP$676
- AbbVie$523
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$441
- Otsuka America Pharmaceutical, Inc.$265
- Lundbeck LLC$146
- Takeda Pharmaceuticals U.S.A., Inc.$130
- plus $464 from 14 others
What the payments were for
- Consulting fees$55021%
- Food & beverage$2,09179%
- Education$50%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neos Therapeutics, LP | 3 | $676 |
| AbbVie(2 entities) | 22 | $523 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 21 | $441 |
| Otsuka America Pharmaceutical, Inc. | 11 | $265 |
| Lundbeck LLC | 8 | $146 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $130 |
| Alkermes, Inc. | 4 | $76 |
| Bausch Health US, LLC | 3 | $57 |
| Inspire Medical Systems, Inc. | 2 | $56 |
| Johnson & Johnson | 2 | $49 |
| Lilly USA, LLC | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $31 |
| Shire North American Group Inc | 2 | $30 |
| Arbor Pharmaceuticals, Inc. | 2 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| Corium, LLC | 1 | $18 |
| Tris Pharma Inc | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Jazz Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Adzenys XR-ODT$668
- Cotempla XR-ODT$668
- VRAYLAR$115
- REXULTI$112
How this compares
$2,646 in reported general payments places this provider in the 85th percentile of 301 child & adolescent psychiatry providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Paliperidone ErPaliperidone | 14 | $2,018 |
| Dexmethylphenidate Hcl ErDexmethylphenidate Hcl | 12 | $1,200 |
| Bupropion XlBupropion Hcl | 60 | $1,093 |
| Duloxetine Hcl | 28 | $652 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 16 | $645 |
| Risperidone | 28 | $531 |
| Buspirone Hcl | 18 | $526 |
| Guanfacine Hcl ErGuanfacine Hcl | 12 | $517 |
| Aripiprazole | 17 | $479 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 14 | $425 |
| Trazodone Hcl | 53 | $367 |
| Lamotrigine | 39 | $325 |
| Escitalopram Oxalate | 19 | $228 |
| Eszopiclone | 12 | $175 |
| Clonazepam | 15 | $96 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in Austin
- Bennett LeventhalAustin$7K
- Raghu GandhiAustin$2K
- Alain KaticBellaire$106K
- Steven PliszkaSan Antonio$59K
- Mary Garcia HolguinSan Antonio$24K
- John SteffekSpring$14K
- Robert MosquedaEdinburg$13K
- Gloria BrunGreenville$10K
- Mudassar TariqSugar Land$9K
- Charles PryzantDallas$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.